Continuous glucose monitoring (CGM) represents one of the most commercially robust sectors within medical technology, ...
On October 9th, 2026, private growth equity firm Sopris Capital finalised the acquisition of medical imaging artificial ...
Europe and the UK are overhauling healthcare AI oversight, shifting from static approvals to continuous lifecycle monitoring ...
The National Health Service (NHS) is currently undergoing a fundamental transformation, mandated by the government’s 10 Year Health Plan, which prioritises the shift from analogue to digital ...
FemTech is undergoing its most consequential structural shift since the term was coined in 2016. What began as a cycle-tracking utility is maturing into a precision medicine category spanning hormonal ...
The global financial landscape has entered an era defined by the institutionalisation of private markets, where the traditional boundaries between equity, credit, and infrastructure have blurred in ...
The medical technology landscape in 2026 is defined by a paradigm shift from pandemic-era stabilisation to a focused era of precision consolidation. This period represents the maturation of several ...
The high street wellness phenomenon represents a fundamental structural transformation of England’s town and city centres, shifting the core economic function from cyclical, transactional retail ...
OpenEvidence entered 2026 on an extraordinary growth arc. In January 2026, the Miami-based company closed a $250 Million Series D led by Thrive Capital and DST Global, doubling its valuation to $12 ...
Quantum Health, headquartered in Columbus, Ohio, has established itself as a leading provider of care coordination and benefits navigation solutions, primarily serving self-insured employers across ...
The trajectory of health technology, encompassing MedTech, diagnostics and digital health tools, from conceptualisation to routine clinical utilisation in the UK is defined by a multi-stage pathway ...
HealthTech and MedTech IPO Predictions 2026: The Discipline Shift and AI-Driven Resurgence The Initial Public Offering (IPO) landscape for the HealthTech and MedTech sectors is projected to undergo a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results